Enveda Drug Discovery Platform
AI-powered platform that reads and translates nature's hidden chemistry at unprecedented speed and scale
Platform · OtherCompany source
Company profile
About Enveda Biosciences
Enveda Biosciences is a drug discovery company that leverages artificial intelligence and advanced chemistry to unlock the medicinal potential of the natural world. The company has developed a proprietary platform that can read and translate nature's hidden chemistry at unprecedented speed and scale, addressing a fundamental challenge in pharmaceutical research: nearly half of all medicines in pill form originate from molecules found in nature, yet almost the entirety of the natural world remains a chemical mystery due to the time and cost of purifying, identifying, and characterizing individual molecules from complex mixtures. Enveda's technology puts billions of years of evolutionary intelligence into the hands of drug hunters, enabling the discovery of medicines 4X faster than the industry average. The company's mission is to give hope to millions of people worldwide by accelerating the discovery of better, life-saving and life-enhancing medicines. With operations in Boulder, Colorado and Hyderabad, India, Enveda is building a pipeline of novel therapeutics derived from nature's vast chemical library.
Company description Enveda Biosciences official website
Primary marketDrug Discovery & Development
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Enveda Biosciences?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
No clinical focus areas are currently listed.
Who it serves
- Pharma
Deployment & integration
Other deployment with recorded integration context.
Geographic context
MarketsIndia · USA
Company sourceOfficial website
Company milestones
Platform expansion
Company has established operations in both Boulder, CO and Hyderabad, India; actively building drug pipeline
Partnerships
Recorded partners
No partners are currently listed.
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Evaluating the generalizability of graph neural networks for predicting collision cross section.Journal of cheminformatics · Aug 29, 2024
Productive mRNA Chromatin Escape is Promoted by PRMT5 Methylation of SNRPB.bioRxiv : the preprint server for biology · Aug 12, 2024
Natural Products Have Increased Rates of Clinical Trial Success throughout the Drug Development Process.Journal of natural products · Jul 26, 2024
Weighting Low-Intensity MS/MS Ions and m/z Frequency for Spectral Library Annotation.Journal of the American Society for Mass Spectrometry · Feb 7, 2024
A Comprehensive Evaluation of Biomedical Entity Linking Models.Proceedings of the Conference on Empirical Methods in Natural Language Processing. Conference on Empirical Methods in Natural Language Processing · Dec 1, 2023
Exploring the known chemical space of the plant kingdom: insights into taxonomic patterns, knowledge gaps, and bioactive regions.Journal of cheminformatics · Nov 10, 2023
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
4X faster drug discovery
compared to industry average
Access to 99.9% of natural world chemistry
previously inaccessible due to cost and time constraints
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Enveda Biosciences
Recent articles published on Enveda Biosciences's official website.
Survival of the Fittest: Nature’s Solution to Surviving Clinical Trials
Read on Enveda BiosciencesIn-VedaTM: Insights into Enveda. Insights into knowledge.
Read on Enveda BiosciencesRediscovering Therapeutic Roots: How Ethnobotany Aids Drug Discovery
Read on Enveda BiosciencesBreaking Barriers: Simultaneous Target and Drug Discovery at Scale
Read on Enveda BiosciencesArtemisinins, Malaria, and The Quest to Systematize Collaboration between Nature and Scientists (Cures and Nobel Prizes)
Read on Enveda Biosciences07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Drug Discovery & Development
Companies using AI, machine learning, or computational biology to discover new drug candidates, identify drug targets, predict drug efficacy, or accelerate pharmaceutical development. Includes both small molecule and biologics development, precision oncology drug discovery, and AI-driven target identification and molecule design.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.